Semapimod

CNI-1493 · Ferring Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Semapimod, covering 2023-11-09 to 2025-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease [Phase 2]